You are here

  • Home
  • Archive
  • Volume 82, Issue 7
  • Correspondence on ‘Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: a monocentric survey’

Article Text

Article menu
Download PDFPDF
Correspondence
Correspondence on ‘Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: a monocentric survey’
  1. Fernando Montero1,
  2. Isabel Castrejón1,2,
  3. Julia Martínez-Barrio1,2,
  4. Juan Carlos Nieto-González1,2,
  5. Javier Rivera1,2,
  6. José María Álvaro-Gracia1,2,
  7. Juan Molina Collada1,2
  1. 1 Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain
  2. 2 Instituto de Investigacion Sanitaria Gregorio Marañón, Madrid, Spain
  1. Correspondence to Dr Juan Molina Collada, Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid 28007, Spain; molinacolladajuan{at}gmail.com

https://doi.org/10.1136/annrheumdis-2021-220941

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We read with great interest the paper published by Tomelleri et al 1 on ‘Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: a monocentric survey’. The authors aimed to evaluate the impact of COVID-19 and national lockdown among patients with large-vessel vasculitis (LVV) in a single centre by April 2020. First, we would like to congratulate them for the novelty of their work during the first wave of the pandemic in Italy. The implementation of ultrasound (US) fast-track pathways (FTPs) in rheumatology, aiming at an early diagnosis of giant cell arteritis (GCA), has led to a decrease in permanent vision loss.2 However, the COVID-19 pandemic lockdown has had a negative impact on patients with GCA, leading to difficulties in monitoring, reduced access to temporal artery biopsy3 and a decline in referral rates of patients accompanied by cases with delayed presentation and vision loss.4 Additionally, recent data suggest that COVID-19 seems to be more severe in patients with LVV with higher rates of hospitalisation and lethality,5 although these results should be further confirmed. The aim of our analysis was to assess the …

    View Full Text

    Footnotes

    • Twitter @jmolinacollada

    • Contributors All authors made substantial contributions to the conception and design of this study. Subject recruitment and ultrasound examination were performed by JMC. JMC and FM collected the epidemiological and clinical data and performed the statistical analysis and study design. FM, IC, JM-B, JCN-G, JR, JMA-G and JMC drafted the manuscript. All coauthors revised the final manuscript.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient and public involvement Patients and/or the public were not involved in the design, conduct, reporting or dissemination plans of this research.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    Linked Articles